Cleared Traditional

K924439 - BECTON DICKINSON INTERLINK VIAL ACCESS CANNULA

K924439 is an FDA 510(k) clearance for BECTON DICKINSON INTERLINK VIAL ACCESS ..., manufactured by Bd Becton Dickinson Vacutainer Systems Preanalytic. The device is a Class 2 General Hospital device with product code FMI cleared through the Traditional 510(k) pathway after a 164-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1993
Decision
164d
Days
Class 2
Risk

K924439 is an FDA 510(k) clearance for the BECTON DICKINSON INTERLINK VIAL ACCESS CANNULA. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Bd Becton Dickinson Vacutainer Systems Preanalytic (Franklin Lakes, US). The FDA issued a Cleared decision on February 12, 1993 after a review of 164 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K924439

510(k) Number K924439 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 01, 1992
Decision Date February 12, 1993
Days to Decision 164 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
35d slower than avg
Panel avg: 129d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 695
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K924439.
SURGICAL DYNAMICS DISCOGRAPHY SYSTEM
K921950 · Surgical Dynamics, Inc. · Jun 1993
NEEDLE-PRO CARTRIDGE
K923127 · Concord/Portex · Apr 1993
B-D PEN NEEDLE
K924070 · Bd Becton Dickinson Vacutainer Systems Preanalytic · Mar 1993
LIFESHIELD VIAL ADAPTER
K920737 · Abbott Laboratories · Dec 1992
PROTECTOR SYRINGE SAFETY CAP SYSTEM
K922158 · Injectimed, Inc. · Jul 1992
NEEDLEGARD II
K920717 · Ingenious Technologies Corp. · Apr 1992